Previous Next Accountability State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits” Abstract: In a letter to the drug maker, the state treasurers warn that prices “disconnected from market forces will ultimately backfire." Publication: STAT Date Published: September 17, 2020 Author(s): Ed Silverman View This Resource